Patent · US Active

Eicosapentaenoic acid (EPA) formulations

US10123986B2 · kind B2 · utility

1Cited by
90References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 18, 2013
Grant dateNov 13, 2018
Priority date
Expiry dateAug 1, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA23V2002/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are compositions comprising eicosapentaenoic acid (EPA) and polar lipids (e.g., glycolipids and phospholipids), and which do not contain any docosahexaenoic acid (DHA) or esterified fatty acids.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.